Cangrelor - Latest Advances

Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: April 07, 2026

Safety and Feasibility of Same-Admission Transcarotid Arterial Revascularization Prior to Heart Surgery for Patients Presenting With Concurrent, Severe Carotid Artery Stenosis, and Surgical Cardiac Disease.

Journal: HCA healthcare journal of medicine

Published: March 11, 2026

Factors influencing the interpretation of meta-analytic findings in cangrelor research.

Journal: Critical care (London, England)

Published: March 06, 2026

The use of mechanical thrombectomy in patients with STEMI and large thrombus burden: design and rationale of the NATURE trial.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: January 23, 2026

Hippocampal GPR17 is involved in chronic restraint stress-induced depressive-like behaviors by regulating neuroinflammation and glutamatergic activity in mice.

Journal: International immunopharmacology

Published: December 24, 2025

Cangrelor in ST-segment elevation myocardial infarction with high on-treatment platelet reactivity: a pilot randomized trial.

Journal: Journal of thrombosis and thrombolysis

Published: December 24, 2025

Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.

Journal: International journal of cardiology

Published: December 19, 2025

Intravenous cangrelor as rescue therapy for acute thrombosis in neuroendovascular procedures: illustrative cases.

Journal: Journal of neurosurgery. Case lessons

Published: December 12, 2025

Parenteral Antiplatelets: Game Changers for Prognosis in Cardiogenic Shock?

Journal: JACC. Cardiovascular interventions

Published: December 02, 2025

Impact of Cangrelor on Outcomes After Percutaneous Coronary Intervention for Acute Coronary Syndrome in High Bleeding Risk Patients.

Journal: The American journal of cardiology

Published: November 24, 2025

Comparative Effects of P2Y12 Inhibitors on Thrombus Biology and Inflammatory Responses in Atherothrombotic Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials.

Journal: Cureus

Published: October 31, 2025

Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Journal: Critical care (London, England)

Published: October 27, 2025